AbbVie Inc. (ABBV) vs Exxon Mobil Corporation (XOM)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Exxon Mobil Corporation is an integrated oil and gas company engaged in the global exploration, production, and refining of petroleum. In 2025, the company produced 3.3 million barrels of liquids per day and 8.4 billion cubic feet of natural gas daily. As of the end of 2025, ExxonMobil reported 19.3 billion barrels of oil equivalent in reserves, with liquids accounting for 69% of the total. The company is also among the world’s largest refiners, with total global refining capacity of 4.1 million barrels of oil per day, and ranks as a leading producer of both commodity and specialty chemicals.